NATALIE TAFEL: Open Payments
NPI 1760537229 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$24,004 in 63 payments from 15 companies in 2025. Trend: 2023 $12,594 · 2024 $29,341 · 2025 $24,004
Speaker / faculty: $15,553Travel & lodging: $2,992Consulting: $2,165Food & beverage: $1,506Honoraria: $1,164Speaker / faculty: $625
| Company | Payments | Amount |
|---|---|---|
| Rigel Pharmaceuticals, Inc. | 21 | $16,716 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $2,946 |
| Amgen Inc. | 5 | $2,187 |
| SERVIER PHARMACEUTICALS LLC | 5 | $783 |
| Geron Corporation | 1 | $513 |
| Alexion Pharmaceuticals, Inc. | 2 | $275 |
| Novartis Pharmaceuticals Corporation | 9 | $217 |
| SOBI, INC | 3 | $79 |
| Azurity Pharmaceuticals, Inc. | 2 | $61 |
| Astellas Pharma US Inc | 2 | $56 |
Products named: REZLIDHIA, BLINCYTO, ICLUSIG, Tibsovo, RYTELO, ULTOMIRIS, Fabhalta, TAVALISSE.
Industry payments across NY — which companies pay providers there.
